BELLUS Health Inc.
BLU was delisted on the 28th of June, 2023.
11 hedge funds and large institutions have $6.71M invested in BELLUS Health Inc. in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 98 closing their positions.
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
90% less funds holding
Funds holding: 106 → 11 (-95)
97% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 98
99% less capital invested
Capital invested by funds: $828M → $6.71M (-$822M)
100% less funds holding in top 10
Funds holding in top 10: 7 → 0 (-7)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CG
Carmignac Gestion
Paris,
France
|
+$2.93M |
| 2 |
VAM
Vazirani Asset Management
New York
|
+$1.46M |
| 3 |
GLAM
Gardner Lewis Asset Management
Chadds Ford,
Pennsylvania
|
+$195K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$73.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$91M |
| 2 |
Goldman Sachs
New York
|
-$53.4M |
| 3 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
-$50.7M |
| 4 |
CC
Commodore Capital
New York
|
-$47.4M |
| 5 |
O
OrbiMed
New York
|
-$36.8M |
BLU Hedge Fund Activity: Q2 2023 in Review
11 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in BELLUS Health Inc. (BLU) for Q2 2023, worth a combined $6.71M — down 99% from $828M a quarter earlier.
Sellers outnumbered buyers: 98 funds closed out of BLU and 3 opened new positions — a net loss of 95 holders — while 4 trimmed existing stakes and 1 added.
The largest buyer was Carmignac Gestion, opening a new position worth an estimated $2.93M. The largest seller was RA Capital Management, exiting entirely with an estimated $91M sold.
- 11 institutional investors held BELLUS Health Inc. (BLU) as of Q2 2023, down from 106 in Q1 2023.
- Funds reported $6.71M of BELLUS Health Inc. stock for Q2 2023, down 99% quarter-over-quarter.
- 3 funds opened new BELLUS Health Inc. positions in Q2 2023 and 98 closed out, a net change of -95 holders.
- The largest BELLUS Health Inc. buyer in Q2 2023 was Carmignac Gestion, an estimated $2.93M added.
- The largest BELLUS Health Inc. seller in Q2 2023 was RA Capital Management, an estimated $91M sold.
Based on aggregated 13F filings for Q2 2023.